0001415889-23-003679.txt : 20230301
0001415889-23-003679.hdr.sgml : 20230301
20230301164109
ACCESSION NUMBER: 0001415889-23-003679
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230228
FILED AS OF DATE: 20230301
DATE AS OF CHANGE: 20230301
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Pontes Josias
CENTRAL INDEX KEY: 0001868415
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39746
FILM NUMBER: 23694311
MAIL ADDRESS:
STREET 1: C/O SIGILON THERAPEUTICS, INC.
STREET 2: 100 BINNEY STREET, SUITE 600
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Sigilon Therapeutics, Inc.
CENTRAL INDEX KEY: 0001821323
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 474005543
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 100 BINNEY STREET
STREET 2: STE 600
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
BUSINESS PHONE: 617-336-7540
MAIL ADDRESS:
STREET 1: 100 BINNEY STREET
STREET 2: STE 600
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
4
1
form4-03012023_090358.xml
X0306
4
2023-02-28
0001821323
Sigilon Therapeutics, Inc.
SGTX
0001868415
Pontes Josias
C/O SIGILON THERAPEUTICS, INC.
100 BINNEY STREET STE 600
CAMBRIDGE
MA
02142
false
true
false
false
CHIEF FINANCIAL OFFICER
Stock Option (Right to Buy)
1.09
2023-02-28
4
A
0
140000
0
A
2033-02-27
Common Stock
140000
140000
D
The options vest as to 25% of the underlying shares of common stock on February 28, 2024, the first anniversary of the vesting commencement date, and at a rate of 6.25% of the underlying shares thereafter on the first day of each quarter following such date until the options are fully vested.
/s/ Matthew Kowalsky, Attorney-in-Fact
2023-03-01